Anwar Mulugeta Gebremichael

Dr Anwar Mulugeta Gebremichael

Research Associate, Genetic Epidemiology and Statistical Genetics and Bioinformatics

School of Public Health

College of Health

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.

Dr. Anwar Mulugeta is a Research Associate at the Nutritional and Genetic Epidemiology Research Group. With over five years of experience as a steering committee member at the Australian Centre for Precision Health, he brings a wealth of expertise to his role. Dr. Mulugeta holds a Ph.D. in Genetic Epidemiology (awarded in 2020), an M.Pharm in Medical Pharmacology (completed in 2011), and a B.Pharm in Pharmacy (completed in 2008). He is also affiliated with the Department of Pharmacology and Clinical Pharmacy at Addis Ababa University (AAU), Ethiopia. Prior to this, he served as a Clinical Trial Coordinator for a collaborative project between AAU and Massachusetts General Hospital. Dr. Mulugeta's primary research focus lies in understanding the contributions of genetics and the environment, as well as the intricate interplay between them, in relation to disease risk. His research covers a broad spectrum of health outcomes, including cognitive impairment, dementia, depression, cancers, and various other health conditions. To accomplish this, he employs a diverse range of genetic and bioinformatic approaches, such as Mendelian randomizations, phenome-wide associations, genome-wide associations, gene-environment interactions, and machine-learning techniques.

Year Citation
2026 Pham, K., Mulugeta, A., Lumsden, A., & Hyppӧnen, E. (2026). A multivariable Mendelian randomization study of serum lipids and dementia risk within the UK Biobank. Journal of Nutritional Biochemistry, 148(110160), 1-9.
DOI
2025 Mulugeta, A., Stacey, D., Lumsden, A. L., Madakkatel, I., Lee, S. H., Mäenpää, J., . . . Hyppönen, E. (2025). Protein markers of ovarian cancer and its subtypes: insights from proteome-wide Mendelian randomisation analysis. British Journal Of Cancer, 133(8), 1208-1217.
DOI
2025 Pham, K., Kassaw, N. A., Mulugeta, A., Zhou, A., & Hyppӧnen, E. (2025). Coffee and health outcomes: a systematic review of Mendelian randomisation studies. Nutrition Research Reviews, online(2), 21 pages.
DOI
2025 Yeshaw, Y., Madakkatel, I., Mulugeta, A., Lumsden, A., & Hypponen, E. (2025). Machine learning to discover factors predicting volume of white matter hyperintensities: insights from the UK Biobank. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 17(1, article no. e70090), 1-12.
DOI
2025 Hyppönen, E., Mulugeta, A., & Zhou, A. (2025). Reanalysis of the vitamin D and dementia association using the doubly-ranked nonlinear Mendelian randomization approach. The American Journal of Clinical Nutrition, 122(3), 894-897.
DOI Scopus1
2024 Kassaw, N. A., Zhou, A., Mulugeta, A., Lee, S. H., Burgess, S., & Hyppönen, E. (2024). Alcohol consumption and the risk of all-cause and cause-specific mortality-a linear and nonlinear Mendelian randomization study. International Journal of Epidemiology, 53(2), 1-8.
DOI Scopus14 Europe PMC9
2024 Yeshaw, Y., Madakkatel, I., Mulugeta, A., Lumsden, A., & Hyppönen, E. (2024). Uncovering predictors of low hippocampal volume: evidence from a large-scale machine-learning-based study in the UK biobank. Neuroepidemiology, 58(5), 369-382.
DOI
2024 Mulugeta, A., Lumsden, A., Madakkatel, I., Stacey, D., Lee, S. H., Mäenpää, J., . . . Hypponen, E. (2024). Phenome-wide association study of ovarian cancer identifies common comorbidities and reveals shared genetics with complex diseases and biomarkers. Cancer Medicine, 13(4, article no. e7051), 1-13.
DOI Scopus2 Europe PMC3
2024 Madakkatel, I., Lumsden, A. L., Mulugeta, A., Mäenpää, J., Oehler, M. K., & Hyppönen, E. (2024). Large-scale analysis to identify risk factors for ovarian cancer. International Journal of Gynecological Cancer, 35(8, article no. 101844), 005424-1-005424-9.
DOI Scopus6 WoS6 Europe PMC5
2024 Yalew, M., Mulugeta, A., Lumsden, A. L., Madakkatel, I., Lee, S. H., Oehler, M. K., . . . Hyppönen, E. (2024). Circulating Phylloquinone and the Risk of Four Female-Specific Cancers: A Mendelian Randomization Study. Nutrients, 16(21), nu16213680-1-nu16213680-9.
DOI
2023 Pham, K., Mulugeta, A., Lumsden, A., & Hyppӧnen, E. (2023). Genetically instrumented LDL-cholesterol lowering and multiple disease outcomes: A Mendelian randomization phenome-wide association study in the UK Biobank. British Journal of Clinical Pharmacology, 89(10), 2992-3004.
DOI Scopus5 WoS4 Europe PMC4
2023 Ahmed, M., Mäkinen, V. -P., Lumsden, A., Boyle, T., Mulugeta, A., Lee, S. H., . . . Hyppönen, E. (2023). Metabolic profile predicts incident cancer: A large-scale population study in the UK Biobank.. Metabolism: clinical and experimental, 138(155342), 1-9.
DOI Scopus8 WoS8 Europe PMC4
2023 Madakkatel, I., Lumsden, A. L., Mulugeta, A., Olver, I., & Hyppönen, E. (2023). Hypothesis-free discovery of novel cancer predictors using machine learning. European Journal of Clinical Investigation, 53(10), 1-13.
DOI Scopus4 WoS4 Europe PMC4
2023 Mulugeta, A., Suppiah, V., & Hyppönen, E. (2023). Schizophrenia and co-morbidity risk: Evidence from a data driven phenomewide association study. Journal of Psychiatric Research, 162, 1-10.
DOI Scopus10 WoS8 Europe PMC8
2023 Lumsden, A. L., Mulugeta, A., Makinen, V. P., & Hypponen, E. (2023). Metabolic profile-based subgroups can identify differences in brain volumes and brain iron deposition. Diabetes Obesity & Metabolism, 25(1), 121-131.
DOI
2022 Mulugeta, A., Navale, S. S., Lumsden, A. L., Llewellyn, D. J., & Hyppönen, E. (2022). Healthy lifestyle, genetic risk and brain health: a gene-environment interaction study in the UK Biobank. Nutrients, 14(19, article no. 3907), 1-13.
DOI
2022 Lumsden, A. L., Mulugeta, A., & Hyppönen, E. (2022). Milk consumption and risk of twelve cancers: a large-scale observational and Mendelian randomisation study. Clinical Nutrition, 42(1), 1-8.
DOI
2022 Mulugeta, A., Eshetie, T. C., Kassie, G. M., Erku, D., Mekonnen, A., Lumsden, A., & Hypponen, E. (2022). Association between metabolically different adiposity subtypes and osteoarthritis: a Mendelian Randomization Study. Arthritis Care & Research, 75(4), 885-892.
DOI
2022 Pham, K., Mulugeta, A., Zhou, A., O'Brien, J. T., Llewellyn, D. J., & Hyppönen, E. (2022). High coffee consumption, brain volume and risk of dementia and stroke.. Nutritional Neuroscience, 25(10), 2111-2122.
DOI Scopus26 WoS29 Europe PMC25
2022 Ahmed, M., Mäkinen, V. -P., Mulugeta, A., Shin, J., Boyle, T., Hyppönen, E., & Lee, S. H. (2022). Considering hormone-sensitive cancers as a single disease in the UK biobank reveals shared aetiology. Communications biology, 5(1, article no. 614), 1-14.
DOI Scopus13 WoS12 Europe PMC12
2022 Erku, D., Mersha, A. G., Ali, E. E., Gebretekle, G. B., Wubishet, B. L., Kassie, G. M., . . . Scuffham, P. (2022). A systematic review of scope and quality of health economic evaluations conducted in Ethiopia. Health policy and planning, 37(4), 514-522.
DOI
2022 Navale, S. S., Mulugeta, A., Zhou, A., Llewellyn, D. J., & Hyppönen, E. (2022). Vitamin D and brain health: an observational and Mendelian randomization study. The American Journal of Clinical Nutrition, 116(2), 531-540.
DOI Scopus70 Europe PMC57
2022 Mulugeta, A., Hypponen, E., Ala Korpela, M., & Makinen, V. P. (2022). Cross-sectional metabolic subgroups and 10-year follow-up of cardiometabolic multimorbidity in the UK Biobank. Scientific Reports, 12(1, article no. 8590), 1-11.
DOI
2021 Mulugeta, A., Lumsden, A., & Hyppönen, E. (2021). Relationship between serum 25(Oh)d and depression: causal evidence from a bi-directional mendelian randomization study. Nutrients, 13(1), 1-13.
DOI
2021 Mulugeta, A., Lumsden, A., & Hyppönen, E. (2021). Unlocking the causal link of metabolically different adiposity subtypes with brain volumes and the risks of dementia and stroke: a Mendelian randomization study. Neurobiology of Aging, 102, 161-169.
DOI
2021 Challa, F., Getahun, T., Sileshi, M., Geto, Z., Kelkile, T. S., Gurmessa, S., . . . Teferra, S. (2021). Prevalence of metabolic syndrome among patients with schizophrenia in Ethiopia. BMC Psychiatry, 21(1, article no. 620), 1-9.
DOI
2021 Ahmed, M., Mulugeta, A., Lee, S. H., Mäkinen, V. P., Boyle, T., & Hyppönen, E. (2021). Adiposity and cancer: a Mendelian randomization analysis in the UK biobank. International Journal of Obesity, 45(12), 2657-2665.
DOI Scopus32 WoS27 Europe PMC26
2021 Nichols, E., Abd Allah, F., Abdoli, A., Abosetugn, A. E., Mulugeta, A., & Vos, T. (2021). Global mortality from dementia: application of a new method and results from the global burden of disease study 2019. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 7(1, article no. e12200), 1-28.
DOI Scopus143 WoS106 Europe PMC117
2020 Mulugeta, A., Zhou, A., King, C., & Hyppönen, E. (2020). Association between major depressive disorder and multiple disease outcomes: a phenome-wide Mendelian randomisation study in the UK Biobank. Molecular psychiatry, 25(7), 1469-1476.
DOI Scopus71 WoS72 Europe PMC72
2020 Nicolopoulos, K., Mulugeta, A., Zhou, A., & Hypponen, E. (2020). Association between habitual coffee consumption and multiple disease outcomes: a Mendelian randomisation phenome-wide association study in the UK Biobank. Clinical Nutrition, 39(11), 3467-3476.
DOI Scopus36 Europe PMC33
2020 King, C., Mulugeta, A., Nabi, F., Walton, R., Zhou, A., & Hyppönen, E. (2020). Mendelian randomization case-control PheWAS in UK Biobank shows evidence of causality for smoking intensity in 28 distinct clinical conditions. EClinicalMedicine, 26(100488), 1-7.
DOI Scopus20 WoS20 Europe PMC17
2020 Lumsden, A. L., Mulugeta, A., Zhou, A., & Hyppönen, E. (2020). Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank. EBioMedicine, 59(102954), 1-11.
DOI Scopus202 Europe PMC207
2020 Rollason, V., Mouterde, M., Daali, Y., Cizkova, M., Priehodova, E., Kulichova, I., . . . Desmeules, J. (2020). Safety of the Geneva cocktail, a cytochrome P450 and P-glycoprotein phenotyping cocktail, in healthy volunteers from three different geographic origins. Drug Safety, 43(11), 1181-1189.
DOI
2019 Hypponen, E., Mulugeta, A., Zhou, A., & Santhanakrishnan, V. K. (2019). A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank. The Lancet digital health, 1(3), e116-e126.
DOI Scopus56 Europe PMC62
2019 Tyrrell, J., Mulugeta, A., Wood, A. R., Zhou, A., Beaumont, R. N., Tuke, M. A., . . . Hyppӧnen, E. (2019). Using genetics to understand the causal influence of higher BMI on depression. International journal of epidemiology, 48(3), 834-848.
DOI Scopus166 Europe PMC141
2019 Mulugeta, A., Zhou, A., Vimaleswaran, K. S., Dickson, C., & Hyppönen, E. (2019). Depression increases the genetic susceptibility to high body mass index: Evidence from UK Biobank. Depression and Anxiety, 36(12), 1154-1162.
DOI Scopus37 WoS35 Europe PMC33
2018 Mulugeta, A., Zhou, A., Power, C., & Hyppönen, E. (2018). Obesity and depressive symptoms in mid-life: a population-based cohort study. BMC Psychiatry, 18(297), 1-10.
DOI Scopus53 Europe PMC44
2017 Bilal, A. I., Tilahun, Z., Osman, E. D., Mulugeta, A., Shekabdulahi, M., & Berhe, D. F. (2017). Cosmetics use-related adverse events and determinants among Jigjiga town residents, Eastern Ethiopia. Dermatology and therapy, 7(1), 143-153.
DOI
2016 Bilal, A. I., Osman, E. D., & Mulugeta, A. (2016). Assessment of medicines use pattern using World Health Organization's Prescribing, Patient Care and Health facility indicators in selected health facilities in eastern Ethiopia. BMC health services research, 16(1), 1-8.
DOI
2016 Mulugeta, A., Medhin, G., Yimer, G., Jemal, R., & Fekadu, A. (2016). Quality of clinical trials for selected priority mental and neurological disorders in sub-Saharan Africa: a systematic review. Open access journal of clinical trials, 8, 43-52.
DOI
2015 Shimels, T., Bilal, A. I., & Mulugeta, A. (2015). Evaluation of Ceftriaxone utilization in internal medicine wards of general hospitals in Addis Ababa, Ethiopia: a comparative retrospective study. Journal of pharmaceutical policy and practice, 8(1), 1-8.
DOI
2014 Kiros, Y. K., Teklu, T., Desalegn, F., Tesfay, M., Klinkenberg, E., & Mulugeta, A. (2014). Adherence to anti-tuberculosis treatment in Tigray, Northern Ethiopia. Public health action, 4(S3), S31-S36.
DOI
2014 Borba, C. P. C., Fekadu, A., Teferra, S., Bekele, D., Shibre, T., Oppenheim, C. E., . . . Henderson, D. C. (2014). A placebo-controlled trial of folate with B12 in patients with schizophrenia with residual symptoms in Ethiopia using a sequential parallel comparison design. British journal of medicine and medical research, 4(23), 4090-4104.
DOI
2012 Mulugeta, A., & Chanie, T. (2012). Cause of antiretroviral drug changes among patients on antiretroviral therapy at the art center in Dessei Regional Referral Hospital, Ethiopia. International journal of pharmaceutical sciences and research, 3(1), 120-125.

Date Role Research Topic Program Degree Type Student Load Student Name
2023 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Mr Endeshaw Chekol Abebe
2023 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Mr Melaku Anagaw
2022 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Mr Yigizie Yeshaw Mihiretie
  • Position: Research Associate, Genetic Epidemiology and Statistical Genetics and Bioinformatics
  • Email: anwarmulugeta.gebremichael@adelaide.edu.au
  • Alternative Contact: Tel: 0883021208 Location: SAHMRI, level 8, Southside, Desk number: 87

Connect With Me

External Profiles

Other Links